| 查看: 388 | 回复: 3 | |||
| 当前主题已经存档。 | |||
bioinfuture铁虫 (小有名气)
|
[交流]
急需一篇SCI文章,必有金币酬谢
|
||
|
1: Immunol Res. 1998;18(2):79-92.Links The optimization of helper T lymphocyte (HTL) function in vaccine development.Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A. Epimmune Inc., San Diego, CA, USA. Helper T lymphocyte (HTL) responses play an important role in the induction of both humoral and cellular immune responses. Therefore, HTL epitopes are likely to be a crucial component of prophylactic and immunotherapeutic vaccines. For this reason, Pan DR helper T cell epitopes (PADRE), engineered to bind most common HLA-DR molecules with high affinity and act as powerful immunogens, were developed. Short linear peptide constructs comprising PADRE and Plasmodium-derived B cell epitopes induced antibody responses comparable to more complex multiple antigen peptides (MAP) constructs in mice. These antibody responses were composed mostly of the IgG subclass, reactive against intact sporozoites, inhibitory of schizont formation in liver invasion assays, and protective against sporozoite challenge in vivo. The PADRE HTL epitope has also been shown to augment the potency of vaccines designed to stimulate a cellular immune response. Using a HBV transgenic murine model, it was found that CTL tolerance was broken by PADRE-CTL epitope lipopeptide, but not by a similar construct containing a conventional HTL epitope. There are a number of prophylactic vaccines that are of limited efficacy, require multiple boosts, and/or confer protection to only a fraction of the immunized population. Also, in the case of virally infected or cancerous cells, new immunotherapeutic vaccines that induce strong cellular immune responses are desirable. Therefore, optimization of HTL function by use of synthetic epitopes such as PADRE or pathogen-derived, broadly crossreactive epitopes holds promise for a new generation of highly efficacious vaccines. |
» 猜你喜欢
大龄残疾硕士的一点执念
已经有13人回复
刑法学论文投稿求助
已经有5人回复
今年E04面上
已经有14人回复
Journal of Environmental Chemical Engineering
已经有3人回复
最后一年,祈求好运
已经有3人回复
风电环氧领域
已经有3人回复
2026年面上项目中了,2A+B, 会评顺利通过
已经有8人回复
昨日死,今日生
已经有8人回复
售T0P一区SCI文章,我:8O5.51.O.54,科目齐全,可+急
已经有4人回复
售T0P一区SCI文章,我:8O5.51.O.54,科目齐全,可+急
已经有4人回复
houjinglhy
荣誉版主 (文坛精英)
表达自由,人权之基。
- BioEPI: 1
- 应助: 21 (小学生)
- 贵宾: 0.911
- 金币: 5168.5
- 散金: 3205
- 红花: 137
- 沙发: 93
- 帖子: 10564
- 在线: 913.2小时
- 虫号: 461324
- 注册: 2007-11-18
- 专业: 生物技术药物
- 管辖: 公派出国
★ ★ ★ ★ ★
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48

2楼2009-08-21 00:05:18
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
bioinfuture(金币+15,VIP+0): 8-21 14:49
bioinfuture(金币+15,VIP+0): 8-21 14:49
| 已发送至你的邮箱shengmingbuxi@yahoo.com.cn。 |
3楼2009-08-21 14:45:41
zhangtangw
木虫 (小有名气)
- 应助: 0 (幼儿园)
- 金币: 3192.7
- 帖子: 106
- 在线: 43.5小时
- 虫号: 586366
- 注册: 2008-08-15
- 性别: GG
- 专业: 食品加工学基础
4楼2009-08-30 16:41:11











回复此楼